Skip to content
PICO Portalanswers from OpenAlex

Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center

PaperCitations, authors & open-access status

Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center is a paper indexed in PICO Portal from OpenAlex.

How many citations does Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center have?

PICO Portalcitation count

Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center has 13 citations in the OpenAlex counts PICO Portal stores.

When was Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center published?

PICO Portalyear

Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center has 2018 year in the PICO Portal index.

What is the open-access status of Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center?

PICO Portaloa status

Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center has closed oa status in the PICO Portal index.

What is the DOI of Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center?

PICO Portaldoi

The DOI for Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center is on the source record.

What is the PMID of Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center?

PICO Portalpmid

The PMID for Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center is on the source record.

What is the OpenAlex record for Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center?

PICO Portalopenalex

The OpenAlex for Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial